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Abstract
Mice are exceedingly sensitive to intra-peritoneal (IP) challenge with some virulent pneumococci (LD50=1 bacterium). To
investigate how peripheral contact with bacterial capsular polysaccharide (PS) antigen can induce resistance, we pulsed
bone marrow dendritic cells (BMDC) of C57BL/6 mice with type 4 or type 3 PS, injected the BMDC intra-foot pad (IFP) and
challenged the mice IP with supra-lethal doses of pneumococci. We examined the responses of T cells and B cells in the
draining popliteal lymph node and measured the effects on the bacteria in the peritoneum and blood. We now report that:
1) The PS co-localized with MHC molecules on the BMDC surface; 2) PS-specific T and B cell proliferation and IFNc secretion
was detected in the draining popliteal lymph nodes on day 4; 3) Type-specific resistance to lethal IP challenge was
manifested only after day 5; 4) Type-specific IgM and IgG antibodies were detected in the sera of only some of the mice, but
B cells were essential for resistance; 5) Control mice vaccinated with a single injection of soluble PS did not develop
a response in the draining popliteal lymph node and were not protected; 6) Mice injected with unpulsed BMDC also did not
resist challenge: In unprotected mice, pneumococci entered the blood shortly after IP inoculation and multiplied
exponentially in both blood and peritoneum killing the mice within 20 hours. Mice vaccinated with PS-pulsed BMDC
trapped the bacteria in the peritoneum. The trapped bacteria proliferated exponentially IP, but died suddenly at 18–
20 hours. Thus, a single injection of PS antigen associated with intact BMDC is a more effective vaccine than the soluble PS
alone. This model system provides a platform for studying novel aspects of PS-targeted vaccination.
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Introduction
The protective immune response to a potentially pathogenic
agent is a complex phenomenon involving activations of innate
and adaptive immune cells in response to target antigens, the
elaboration of effector mechanisms, and effects on the pathogen –
all progressing at specific times and in different anatomic
compartments in the host body. Here we set out to develop
a comprehensive model system that could serve as a platform for
observing different aspects of the immune response and for
detecting particular immune reactions in need of in-depth analysis.
We focused on inducing resistance in mice to IP challenge with
highly virulent Streptococcus pneumoniae – a pathogen of which one
bacterium suffices to kill 50–100% of naı ¨ve mice within 24 hours.
The target antigen was the capsular polysaccharide (PS).
The pathogenicity of Streptococcus pneumoniae has been attributed
to the PS antigen of the bacterial surface [1,2]. There are about 90
different pneumococcal PS serotypes that act as the major
virulence factor of the bacteria. Vaccines against pneumococci
have been traditionally based on PS antigens, and anti-PS
antibodies have been known to mediate resistance to the bacterial
infection [3,4]. However, PS vaccines are poorly immunogenic,
especially in young children, the elderly, and immunosuppressed
persons [5,6,7]. The PS antigens are T-cell independent type 2
(TI-2) and activate B cells directly to secrete IgM Abs with no
immunological memory. A new generation of pneumococcal
vaccines has been designed in which the PS antigen is conjugated
to a carrier protein immunogenic for helper T cells [8]. However,
there have been few studies of the possible role of innate
mononuclear antigen presenting cells like dendritic cells (DC)
and macrophages in the activation of the immune response to the
PS.
DC are professional APC, able to internalize exogenous
antigens, migrate to draining lymph nodes (LN) and prime T
cells [9,10,11]. These activities are enhanced by inflammatory
components that stimulate toll-like receptors (TLR) inducing DC
maturation. Previously we showed that TLR4 stimulation of
macrophages or bone marrow-derived dendritic cells (BMDC) in
vitro followed by pulsing with pneumococcal PS type 4 (PS4) led to
the internalization of the PS followed by its appearance on the cell
surface for prolonged times and, upon IP injection to naı ¨ve mice,
induced long-lasting, type-specific resistance to challenge IP with
lethal numbers of pneumococci. This resistance could not be
accomplished by immunization with soluble PS4 [12].
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successful pneumococcal vaccination by PS-pulsed BMDC, in-
cluding the nature of the host immune response and the
mechanism of resistance. We injected mice intra-footpad (IFP)
with soluble PS, with unpulsed BMDC, or with the PS-pulsed
BMDC and challenged the mice intraperitoneally (IP) with lethal
doses of pneumococci. We investigated the cellular responses
developing in the draining popliteal LN and the effects exerted on
the bacteria as a function of induced resistance.
Results
Immunization with PS4-BMDC either IP or IFP induces
resistance to Pn4 bacteria injected IP
We previously reported that resistance to a lethal challenge with
Pn could be induced by vaccination with a macrophage line or
with BMDC that had been pulsed with the PS of the challenge Pn
serotype. Moreover, macrophages or BMDC that had been
activated with a TLR4 agonist were more effective vaccines [12].
In these experiments, both the vaccination and the challenge were
carried out IP, and one could argue that the resistance to challenge
was induced locally rather than systemically. To examine this
issue, we vaccinated mice with PS4-pulsed BMDC administrated
either IP or IFP (5610
6 cells per mouse); the BMDC had been
activated or not with the TLR4 ligand LPS before being pulsed
with PS4. Three weeks later, the mice were challenged IP with
a supra-lethal dose of Pn4 (LD506100,000). Figure 1A shows that
both IFP and IP administration were equally effective in inducing
resistance to the IP challenge. As we reported earlier [12], LPS-
activated BMDC were more effective vaccines. Thus, vaccination
with PS4-pulsed BMDC IFP was as effective as IP vaccination. In
the experiments reported here, we vaccinated IFP and challenged
IP.
Vaccination is PS-specific and does not induce non-
specific bystander protection
To examine whether vaccination with PS-pulsed BMDC is
serotype specific, we vaccinated mice with BMDC pulsed with
either PS type 4 or PS type 3, two different serotypes of
pneumococcal PS with different carbohydrate structures [13,14].
Three weeks later, the mice were challenged IP with Pn bacteria
type 4 or type 3 or with a mixture of Pn4 and Pn3. Figure 1B
shows that protection was PS type-specific: mice immunized with
PS4 were protected against Pn4 and not against Pn3 and vice
versa. In addition, mice immunized with PS4-BMDC or with PS3-
BMDC were not protected against a challenge with both Pn3 and
Pn4 mixed together injected IP; this indicates that the effector
mechanism that kills the Pn is antigen specific and does not affect
adjacent bacteria. The following experiments were done to explore
the requirements for the induction of resistance.
Intact PS4-pulsed BMDC are required to induce
resistance
Previously we reported that intact RAW macrophage line cells
were required to vaccinate recipient mice: Living irradiated RAW
or intact RAW cells killed by fixation were effective, but lysed
RAW did not induce resistance [12]. To see if BMDC behaved
similarly, we treated PS4-pulsed BMDC in three ways before
vaccination: lysis of the living cells; sonication of the living cells; or
glutaraldehyde (GH)-fixation of the cells. Figure 1C shows that the
GH-fixed BMDC vaccine was less effective than live, intact
BMDC. Lysed or sonicated BMDC or the injection of soluble LPS
and PS4 were not effective at all in inducing resistance. Also
ineffective was the injection of the same number of T cells or B
cells that had been incubated with LPS and pulsed with PS4.
Therefore the induction of resistance to Pn challenge is a property
of intact, live BMDC that have been activated by LPS and pulsed
with PS4. Intact BMDC fixed with GH were partially effective
vaccines.
Pulsed PS appears on the surface of both LPS-stimulated
and non-stimulated BMDC in association with MHCI, II
and CD1d presenting molecules
Previously we reported that LPS stimulation of RAW cells
induced the late appearance of PS4 on the cell surface in clusters
[12]. Here, we examined the presence of pulsed PS4 on the surface
of LPS-stimulated or non-stimulated BMDC, and tested whether
the PS4 is associated with presenting molecules on the cell surface.
LPS-stimulated or non-stimulated BMDC were pulsed with PS4
that had been labeled with Alexa633 and the presence of labeled
PS4 was assayed by flow cytometry and by fluorescent microscopy
at various times after incubation at 37uc or on ice. Labeled PS4
appeared equally on the surface of LPS-stimulated and non-
stimulated BMDC in increasing amounts over 2 hours (Fig. 2A),
but only when the BMDC were incubated at 37uc. PS4 was
present on the surface in clusters after 60 minutes incubation at
37uc and in co-localization with CD1, MHC-I and MHC-II
presenting molecules, but not in association with the non-
presenting molecule CD11c (Fig. 2B). The level of PS4 associated
with the BMDC rose with time at 37uc but the PS4 level remained
low when the BMDC were incubated on ice (Fig. 2A); this
indicates that surface presentation of PS4 is a process that requires
a physiological temperature. In contrast to what was found in
macrophages [12], BMDC showed the same level of PS4 on the
surface whether the cells had been stimulated or not with LPS,
although the LPS-stimulated BMDC were more effective than the
non-stimulated BMDC in the induction of resistance to the
bacterial challenge (Fig. 1A).
Presenting, co-stimulatory and migrating molecules
expressed on PS4-BMDC are important but not necessary
to induce resistance
We showed above that the pulsed PS4 appears on the surface of
the BMDC clustered with molecules known to be involved in
antigen presentation (Fig. 2B). To learn whether expression of
these presenting molecules on the injected BMDC is required for
the induced resistance, we used BMDC derived from mice
genetically lacking beta2M (MHCI and CD1 deficient) or lacking
MHC class II molecules. In addition, we examined the effective-
ness of BMDC that lacked the expression of CD80 and CD86,
costimulatory molecules required for T cell priming, and of
CCR7, a chemokine receptor molecule required for DC migration
[15]. The BMDC derived from these C57BL/6 deficient mice and
from control wild-type mice were pulsed with PS4 and injected
into wild-type C57BL/6 mice. Three weeks later the mice were
challenged with a supra-lethal dose of Pn. Figure 3 shows that the
vaccinations with PS4-BMDC that lacked the presenting, co-
stimulatory or migrating molecules were about 50% less effective
compared to vaccination with wild-type BMDC. Nevertheless,
a significant number of mice vaccinated with these deficient
BMDC did resist challenge compared to non-vaccinated control
mice. These results suggest that the association of PS4 on the
surface with MHC class I and class II presenting molecules and the
expression of CD80, CD86 and CCR7 molecules is important for
the induction of the most effective immune resistance to Pn4
challenge. However, a significant measure of resistance can be
Pulsed Dendritic Cells Induce Bacterial Resistance
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pulsed BMDC. This finding raises the question of whether the PS
antigen might be taken up by antigen-presenting cells resident in
the host mice.
PS4 on the surface of the injected BMDC is transferred to
host cells
To detect the possible transfer of PS4 from the injected donor
BMDC to host cells, we injected the donor cells IP and tested
whether labeled PS4 could be detected in host cells isolated from
the peritoneum. For these experiments we used the allotypic
mouse system: Donor BMDC derived from CD45.2 mice were
stimulated with LPS for 24 hours and pulsed with PS4-Alexa 633
for 1 hour. The cells were then injected IP to CD45.1 host mice.
As a control, BMDC pulsed with unlabelled PS4 were also
injected. After 24 hours, the mice were sacrificed and the
peritoneal fluid was collected. The peritoneal cells were analyzed
by FACS to detect the labeled PS4. PS4 was found in association
with both CD45.2 donor BMDC and CD45.1 host cells (Fig. 4). In
fact, more CD45.1 host cells were co-labeled with PS4-Alexa633
compared to the CD45.2 donor cells. These results suggest that the
induction of the immune response to the PS4 involves both the
PS4 present on the surface of the injected BMDC and the transfer
of PS4 to host cells, possibly antigen presenting cells.
It is important to note, however, that injection of the PS4
antigen alone or of lysed PS4-BMDC failed to induce resistance to
challenge (Fig. 1C); under these circumstances, PS4 was not
rendered immunogenic by host APC. Thus, intact antigen-pulsed
donor BMDC are required to realize the possible contribution of
host monocytes or other cells to the resistance to lethal challenge
measured in these studies. The following series of experiments
were done to gain some insights into the immune response of the
hosts responsible for the resistance induced by the donor PS4-
BMDC.
Immunization IFP induces lymphocyte proliferation in
the draining popliteal LN on day 4
The first lymphoid organ that might be expected to respond to
activated BMDC introduced into the subcutaneous tissue of the
foot pad would be the draining popliteal LN. To examine the
Figure 1. Vaccination with type-specific PS-pulsed BMDC induces type-specific resistance: Only intact BMDC are effective. (A) LPS-
stimulated (LPS) and non-stimulated (2) BMDC were pulsed with PS4 and injected once IP or IFP to C57BL/6 mice (5610
6 cells per mouse). Three-
weeks later, the mice were challenged with Pn4 (100,0006LD50 CFU) IP: *p,0.05 +LPS+PS4 compared to 2LPS+PS4, +LPS2PS4 and 2LPS2PS4,
n=25. (B) LPS-stimulated or non-stimulated BMDC were pulsed with PS4 or PS3 and injected IFP to C57BL/6 mice. Three weeks later, the mice were
challenged with Pn4 or Pn3 or with a mixture of both Pn4 and Pn3 IP: *p,0.05 +LPS+PS4, Pn4 compared to +LPS+PS3, Pn4, +LPS2PS, Pn4 and to all
groups of Pn4+Pn3. **p,0.05 +LPS+PS3, Pn3 compared to +LPS+PS4, Pn3, 2LPS2PS, Pn3 and to all groups of Pn4+Pn3, n=15. (C) LPS-stimulated,
PS4-pulsed BMDC were fixed with glutaraldehyde 1%, lysed with DDW, sonicated (sonic.) or were not treated (untreat.). The cells were then injected
into recipient mice. Control LPS-stimulated and PS4-pulsed splenic (sple.) T and B cells or soluble LPS+PS4 were injected to other groups of mice.
After three weeks, the mice were challenged with Pn4 (100,0006LD50): *p,0.05 untreated BMDC compared to all groups, n=10.
doi:10.1371/journal.pone.0039193.g001
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conducted a time-course experiment: mice were immunized IFP
with BMDC unpulsed or pulsed with PS4, and after 2, 4, 5, 6 or
12 days, the mice were sacrificed and the popliteal draining LN
cells were isolated. Figure 5A shows that the numbers of LN cells
increased from ,1610
6 cells in the naı ¨ve mice (time 0) to ,8610
6
cells after 4 days, then decreased to ,2610
6 cells after 12 days.
There was no significant difference in the numbers of LN cells in
the PS4-BMDC and BMDC injected mice. Yet the PS4-BMDC
injected mice were resistant to the Pn4 challenge whereas the
BMDC injected mice were not (Fig. 1A). The LN cells of the mice
that had been injected with PS4-BMDC also manifested a pro-
liferative response to PS4: Figure 5B shows that proliferation of
lymphocytes was detected only on day 4 after IFP injection of PS4-
BMDC, but not before or after. Mice that had been injected IFP
with unpulsed BMDC showed no proliferative response to PS4.
Moreover, the immunization IFP with PS4-BMDC did not induce
activation of the non-draining LN or spleen at any of the time
points measured (data not shown).
To examine whether the proliferation was antigen-specific, we
immunized mice with BMDC pulsed with either PS4 or PS3, or
with soluble PS4 or PS3+LPS and examined the proliferation of
cells from the draining popliteal LN 4 days later. Figure 5C shows
that the LN cells of the PS4-BMDC injected mice proliferated
Figure 2. PS4 is present on the surface of BMDC in association with presenting molecules. BMDC were stimulated with LPS and pulsed
with Alexa633-labeled PS4 for 5, 30, 60 and 120 minutes at 37uco r4 uc. The cells were then washed and monitored by flow cytometry (A), or were
also stained for surface markers: anti-CD1d-PE, anti-H-2K
b(MHCI)-FITC, anti-I-A
b(MHCII)-PE, CD11c-PE, and were examined by fluorescent microscopy
(B). Surface marker staining is presented in green; Alexa633-PS4 in red; the co-localization of both of them is detected by the yellow color.
doi:10.1371/journal.pone.0039193.g002
Figure 3. Deficiency of presenting and migrating molecules
expressed on PS4-BMDC reduces the efficacy of induced
resistance. BMDC derived from b2M, MHCII, CD80/86, CCR7 deficient
or WT C57BL/6 mice were stimulated with LPS, pulsed with PS4 and
injected IFP into WT mice. Un-pulsed WT BMDC were injected as
a control (WT un-pulsed). Three weeks later, the mice were challenged
with Pn4 IP. *p,0.05 WT compared to all the groups, n=15–20.
doi:10.1371/journal.pone.0039193.g003
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BMDC injected mice responded to PS3 and not to PS4. Cells
isolated from the mice that had been injected with soluble
LPS+PS4 or LPS+PS3 did not proliferate (Fig. 5C) and were
similar in size to naı ¨ve un-injected mice (data not shown).
IFNc secretion by LN cells
Proliferation of lymphocytes is often associated with the
secretion of cytokines. The supernatants of the cultured LN cells
were collected and tested by ELISA for IFNc (for a Th-1 type
response), IL-17 (for a Th-17 type response) or IL-10 (for a Th-2
type response). Figure 5D shows that the proliferating lymphocytes
secreted IFNc specifically when cultured with PS4, in a dose-
dependent manner. No IL-17 or IL-10 was detected in the
supernatants, suggesting a Th-1 type response.
Thus induction of resistance to bacterial challenge (Figure 1A) is
associated with serotype-specific proliferation and cytokine secre-
tion detected in the draining LN; soluble PS failed to induce either
proliferation or resistance.
Both B cells and T cells proliferate on day 4 in the
popliteal LN
To examine which population of LN cells proliferated, we
isolated cell suspensions from the draining LN 4 days after IFP
injection of PS4-BMDC, labeled the LN cells with the fluorescent
dye CFSE and cultured the cells with or without PS4. After
85 hours in culture, the cells were collected, stained with anti-CD3
Abs (to detect T cells) or anti-CD19 Abs (to detect B cells) and
assayed by flow cytometry. Figure 5E shows that immunization
IFP induced PS4-specific proliferation of both CD3+ T cells and
CD19+ B cells. Popliteal LN of mice immunized with un-pulsed
BMDC did not manifest cell proliferation.
Resistance to Pn4 challenge is manifested only after 5
days
Since lymphocyte proliferation was detected in the draining LN
only after 4 days, we investigated whether the minimal time
required for the induction of resistance might be associated with
this antigen-specific T cell and B cell proliferation. Mice were
immunized with PS4-BMDC and then were challenged IP after 2,
4, 5, 6, or 7 days. Resistance to challenge IP was observed only
after 5 days (Fig. 5F), suggesting that the minimal time required for
the processes necessary for the establishment of resistance in the
peritoneum is subsequent to antigen-specific lymphocyte pro-
liferation in the draining LN. The following experiments were
done to learn whether induced resistance depended on recipient T
cells, B cells or both.
Immunized mice deficient of B cells are susceptible to
the Pn4 challenge, whereas, immunized mice deficient of
abT cells or cdT cells acquire resistance
It has been reported that a rapid immune response to bacterial
infection is induced by cdT cells that respond within hours [16].
IFNc secretion by T cells can originate from Th-1 helper T cells or
from cdT cells. To test whether the induction of resistance
requires functional T cells (conventional abTo rcdT cells) or B
cells, we immunized mice deficient of conventional T cells
(TCRb2/2), cdT cells (TCRd2/2) or B cells (JHT) with PS4-
BMDC. Three weeks later, we tested the resistance of the mice to
Pn challenge. Surprisingly, mice deficient in cdT cells or abT cells
were resistant whereas mice deficient in B cells were susceptible to
the Pn4 challenge (Fig. 6). This result indicates that the recipient B
cells are required for the induced resistance; abT cells or cdT cells
appear not to be essential in the mechanism of the induced
resistance, although proliferation of PS-specific CD3+ T cells and
IFNc secretion were observed in association with the proliferation
of B cells and the acquisition of resistance in mice with intact T cell
populations (Fig. 5D).
Immunization with PS-pulsed BMDC induces specific
anti-PS IgM and IgG Ab production, however, Abs could
not be detected in the sera of some of the protected
mice
We assayed the serum levels of anti-PS4 IgM and IgG
developing in mice that had been immunized IFP with PS4-
pulsed BMDC, activated or not with LPS, or with LPS-activated
BMDC. The mice were bled after 5 days or 3 weeks, and serum
samples were tested for anti-PS4 Ig Abs by ELISA. Figure 7 shows
that all the mice immunized with PS4-pulsed, LPS-activated
BMDC manifested anti-PS4 IgM Abs 5 days after immunization
that significantly declined by three weeks; these Abs were not
detected in the sera of mice that had been injected with un-pulsed
BMDC or with pulsed BMDC that had not been activated with
LPS. However, only about 20% of the mice that had been injected
Figure 4. PS4 on the surface of BMSC is transferred to endogenous cells in the peritoneum. BMDC derived from CD45.2 mice (donors)
were stimulated with LPS and pulsed with PS4-Alexa633. The cells were injected IP into CD45.1 mice (recipients). After 24 hours, the mice were
sacrificed, cold PBS was injected IP and the peritoneal fluid was collected. The collected cells were stained with anti-CD45.1-PE and anti-CD45.2-FITC,
and were analyzed by flow cytometry. The numbers indicate the percentage of labeled cells.
doi:10.1371/journal.pone.0039193.g004
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later. (A) Mice were immunized IFP with LPS-stimulated, PS4-pulsed BMDC (PS4-BMDC) or with LPS-stimulated, un-pulsed BMDC (BMDC). Two, three,
four, five, six, seven and twelve days later, the draining popliteal LN were isolated, pooled, and mashed and cell counts were performed to determine
the total numbers of cells in the LN. The standard error (SE) is +/21.2, p.0.05. (B) The isolated, pooled lymphocytes of each group were incubated
with PS4 for 85 hours supplemented with H
3-labeled thymidin (added in the last 12 hours). *p,0.05 LPS+DC+PS4, 4 hours compared to all. (C) Mice
were immunized IFP with PS3-BMDC, PS4-BMDC, un-pulsed BMDC, LPS+PS3 or LPS+PS4. Four days after immunization, draining popliteal LN were
isolated, mashed, and incubated in 96-well plates with PS3 or PS4 and H
3-labeled thymidine. *p,0.05 compared to all PS4 and none groups.
**p,0.05 compare to all PS3 and none groups. (D) Mice were immunized IFP with PS4-BMDC or with un-pulsed BMDC. Four days after immunization,
draining popliteal LN were isolated, incubated with PS4 in different doses (0–50 mg/ml) or with Concanavalin A (conA) (1.25 mg/ml), a strong
mitogen, for 85 hours. The supernatants were collected and examined for the presence of IFNc by ELISA. *p,0.05 lymphocytes of PS4-BMDC injected
mice compare to all. (E) Isolated lymphocytes were stained with CFSE and incubated with PS3 or PS4 for 85 hours. The cells were then collected,
stained for anti-CD3-biotin: SA-cy5 or anti-CD19-APC Ab and followed by flow cytometry. (F) Mice were immunized with PS4-BMDC IFP. Two, four,
five, six and seven days later, the mice were challenged with Pn4 bacteria (100,0006LD50) IP. *p,0.05 two or four days after immunization compare
to all groups.
doi:10.1371/journal.pone.0039193.g005
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IgG Ab at 3 weeks, although all these mice were resistant to the
Pn4 challenge. Moreover, bacterial challenge did not induce
detectable IgG antibodies in mice that had resisted the challenge
(in three independent experiments, data not shown). Notably, no
anti-PS4 IgE and IgA Abs were detected (data not shown).
It was conceivable that sera that tested negative in the ELISA
assay might still contain functionally protective antibodies. We
performed passive serum transfer experiments in an attempt to
demonstrate such antibodies. Passive protection from bacterial
challenge (1006LD50) could be demonstrated by passive transfer
of 0.2 ml of serum from donors with antibody-positive sera, but
2 ml of sera from the IgG antibody-negative mice failed to protect
(data not shown). These results collectively show that immuniza-
tion with BMDC pulsed with PS4 indeed induces a PS4-specific B
cell response that is essential for acquired resistance; however the
resistance is not necessarily associated with the presence of
protective anti-PS4 Abs detectable in the serum.
Following Pn challenge in vaccinated mice, the bacteria
are sequestered in the peritoneum and die after initial
replication
The final experiments were done to gain some insight into the
fate of the challenge bacteria in the peritoneum and blood of
vaccinated and control mice. Mice were immunized or not with
PS4-BMDC, and, three weeks later, the mice were challenged with
the Pn4 bacteria (100,0006LD50) and were bled and then
sacrificed at different time points. Sera and peritoneal lavage
samples were examined for numbers of live bacteria by the CFU
counting assay. Figure 8A shows that not a single bacterium could
be detected 0.5–18 hours after Pn challenge in the blood of mice
that had been immunized with PS4-BMDC. In contrast, the mice
immunized with un-pulsed-BMDC, like the naı ¨ve mice, mani-
fested dissemination of the bacteria to the blood and their
logarithmic replication over 4 hours. The numbers of bacteria
reached a plateau and all the control vaccinated mice died by
20 hours after challenge.
Figure 6. Mice deficient of B cells (JHT2/2) immunized with
PS4-BMDC are susceptible to Pn4 challenge. WT, B-cell deficient
(JHT2/2), abT cell deficient (TCRb2/2)o rcdT cell deficient (TCRd2/2)
mice were immunized IFP with PS4-BMDC. Three weeks later, the mice
were challenged with Pn4 bacteria (100,0006LD50) IP (n=10).
doi:10.1371/journal.pone.0039193.g006
Figure 7. Immunization with PS4-BMDC induces short-term
anti-PS4 IgM and long-term anti-PS4 IgG Ab. Mice were
immunized with PS4-BMDC either IP or IFP. Five days and three weeks
after immunization, the mice were bled, and serum samples were
tested for the presence of anti-PS4 IgM and IgG Abs by ELISA. p,0.05
tested by Wilcoxon non-parametric test (n=10–25).
doi:10.1371/journal.pone.0039193.g007
Figure 8. Challenge bacteria are trapped in the peritoneum of
vaccinated mice and do not enter the blood or kill the mice;
the vaccinated mice kill the bacteria after 18–24 hours. Mice
were immunized IFP with PS4-BMDC or with un-pulsed BMDC. Three
weeks later, the mice were challenged with Pn4 bacteria
(100,0006LD50) IP. The mice were bled 0.5, 2, 4, 8, 18 and 24 hours
post-challenge, and peritoneal fluids were collected. The peritoneal
fluid (A) and the blood samples (B) were plated on agar overnight and
CFU were then counted. Note: x means that the mice died and the
samples could not be collected.
doi:10.1371/journal.pone.0039193.g008
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Although not a single bacterium could be detected in the blood of
the PS4-BMDC immunized mice and all the mice resisted
challenge, the injected Pn4 bacteria replicated in the peritoneum
at the same logarithmic rate as did the bacteria in the control
vaccinated or naı ¨ve mice for about 18 hours, after that time point,
all the bacteria died in the effectively vaccinated mice. The naı ¨ve
and control-vaccinated mice died with great numbers of bacteria
in both peritoneum and blood (Fig. 8B). Thus the protective
mechanism induced by PS4-BMDC vaccination upon challenge
immediately confines the bacteria to the site of injection but does
not prevent their replication; an immune response effector
mechanism kills them only about 18 hours later.
Discussion
The experiments described here were undertaken to obtain
a comprehensive look at the induction of resistance to lethal Pn
challenge induced in mice by intra footpad injection of PS-pulsed
BMDC. The PS-pulsed BMDC vaccine was highly effective in
inducing PS-specific resistance to a supra-lethal pneumococcus
challenge; immunization with a PS serotype 4 did not induce
resistance to Pn type 3 bacteria, and vice versa. The PS-pulsed
BMDC vaccine induced long-term systemic protection; and
immunization IFP conferred protection for more than three
months to the bacterial challenge IP. In contrast, immunization
with a single dose of soluble PS (100 mg/ml), with or without the
addition of LPS, did not induce resistance. Moreover, the
resistance appeared to require an intact BMDC cell surface; lysis
or sonication of PS4-pulsed BMDC abolished the induction of
protection, whereas fixation reduced the efficacy of PS4-pulsed
BMDC by 50%. These findings collectively emphasize the
requirement of intact PS4-pulsed BMDC to induce resistance.
Injection of PS4-pulsed BMDC IP led to the transfer of PS4 to
endogenous host cells. However, a single injection of lysed PS4-
BMDC or of PS4 antigen alone failed to induce resistance to the
challenge. Although we could not measure the exact amount of
PS4 released from the lysed BMDC, it would seem that soluble
PS4 at doses of 2.5 mg IFP or 20 mg IP were not rendered
immunogenic by host APC.
PS on the intact surface of BMDC was visually associated with
presenting molecules MHCI, MHCII and CD1d (Fig. 6B). Indeed,
BMDC lacking these presenting or migrating molecules (CD/80,
CD/86 and CCR7) were significantly less effective in inducing
resistance. Presentation of PS molecules is not widely reported in
the literature. However there are some indications that support
this finding: a zwitterionic PS (having both positive and negative
charges) of B. fragilis was shown to be presented to T cells via the
canonical MHC class II pathway [17,18]. Pneumococcal PS
molecules were shown to be taken-up by immature human DC
and transported to HLA-DR and late endosomal compartments
[19]. The lipid determinants of glycolipid antigens were shown to
activate specific T cells via presentation on CD1 [20]. Lai et al
reported that the glycoconjugate is processed and the PS is
associated with MHCII on the cell surface of APC [21]. Further
studies are needed to investigate the molecular interaction of PS4
(a non-zwitterionic molecule) with MHC molecules; it is not clear
whether the clusters of the PS4 we observed on the BMDC surface
form an immunological synapse.
Most anti-bacterial vaccines are evaluated by their ability to
induce high titers of IgG Ab to relevant epitopes. Specifically, the
requirement of anti-PS Ab for the clearance of Pn infection has
long been reported [22,23,24]. Indeed, we showed that B cells are
necessary for the induction of resistance and that the resistance to
challenge by PS-pulsed BMDC was associated with the appear-
ance of specific Abs in the sera of some mice. However,
surprisingly the presence of serum Abs did not always correlate
with the induced resistance; a considerable number of mice
vaccinated with PS4-BMDC produced very little or no detectable
IgG or IgM Ab in their sera, but were, nevertheless, fully resistant
to the Pn challenge. Furthermore, sera derived from immunized
and resistant mice with no detectable anti-PS4 serum Abs failed to
passively confer resistance to naı ¨ve non-immunized mice (data not
shown). We observed a similar phenomenon previously, when we
found that about half of the mice vaccinated with PS conjugated to
an HSP60 peptide made very little to no detectible Ab in their
sera, despite the fact that the conjugate vaccine had endowed these
mice with resistance to lethal Pn challenge [25]. These observa-
tions raise the possibility that the protective Abs might reside in the
peritoneum despite their absence from the serum. Indeed, the lack
of bystander protection across serotypes (Fig. 1) indicates that the
effector mechanism of resistance does discriminate between PS
serotypes.
Along with specific anti-PS Ab in some of the vaccinated mice,
we detected specific activation of lymphocytes in the popliteal LN
draining the site of injection. We found that vaccination with LPS-
stimulated PS-pulsed BMDC induced a marked increase in the
size of the draining popliteal LN and in the number of isolated LN
cells of about 8–10-fold compared to a naı ¨ve popliteal LN.
Interestingly, immunization with LPS-stimulated unpulsed BMDC
induced the same degree of LN enlargement and cell number.
This suggests that the LPS-stimulated BMDC induced a local
inflammatory response in the draining LN leading to a polyclonal
cell proliferation. However, immunization with PS-pulsed BMDC
induced a PS-specific proliferation of lymphocytes detected ex vivo
four days later; this specific proliferative response could not be
induced in mice injected with un-pulsed BMDC; immunization
with PS4 induced proliferation specific to PS4 and not to PS3 and
vice versa; this PS-specific proliferation was limited to day 4.
Interestingly, resistance to lethal Pn challenge IP could be detected
only from day 5 post-vaccination, a day after the LN-cell
proliferation had faded. We found that the proliferation of both
CD3+ T cells and CD19+ B cells was associated with IFNc
secretion in a PS-specific manner. Similarly it was shown by others
that specific CD4+ T cells could respond to meningococcal PS
[26]. Thus, we might hypothesize that the antigen-specific
response detected in the draining LN on day 4 probably plays
a role in the generation of antigen-specific resistance to challenge
detected in response to IP challenge only after day 4.
Despite the induction of PS-specific CD3+ T cell proliferation,
deficiency of either abTo rcdT cells did not affect the induction of
resistance, whereas complete deficiency of B cells did. It is not
clear whether double deficiency of both abT and cdT cells could
affect the induction of resistance. However, it would be premature
to conclude that the T cells responding specifically in the popliteal
LN in wild-type mice (Fig. 5) play no role in the induction of
resistance; T-cell deficient mice develop alternative and compen-
satory mechanisms during development [27] and their immune
systems are not simply the same as the wild-type immune system
but only lacking T cells. Therefore, the roles of the T cell responses
we observed in wild-type mice still need to be resolved. Likewise,
we need to investigate which, if any cells can compensate for the
congenital deficiency of T cells in the response of the knockout
mice to PS-pulsed BMDC. Since both abT and cdT cells can be
the source of IFNc [16,28], it needs to be determined whether
IFNc is secreted in PS4-BMDC immunized TCRb or TCRd
deficient mice and not in the double deficient mice.
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rapid elimination of the bacteria by immune cells [1]. Death from
Gram-positive bacteremia is accompanied by rapid growth of the
bacteria [29] and the release of bacterial components [30]. Death
apparently results from the overwhelming toxic-shock response of
the immune system to bacterial components [30]. In our model,
Pn-induced bacteremia causes death within 24 hours. Naı ¨ve mice
challenged with Pn had over 10 million bacteria (CFU) per ml in
their blood after 0.5 and 2 hours post-challenge before they died.
In contrast, mice immunized with PS4-BMDC had not a single
bacterium detectable in the blood 0.5–18 hours after Pn challenge.
Surprisingly, we found that the injected Pn4 bacteria transiently
replicated in the peritoneum of PS4-BMDC immunized mice and
were eradicated only after about 18 hours. In the unpulsed-
BMDC immunized mice, in contrast, the bacteria continued to
replicate untill the mice died (Fig. 8). We hypothesize that bacteria
may be trapped in leukocytes with delayed killing. Further
experiments will need to be performed to determine if this
hypothesis is correct.
In summary, the results obtained here indicate that PS-pulsed
BMDC can induce specific adaptive responses that were not
elicited by a single injection of the PS antigen itself or by a lysate of
the pulsed BMDC; the draining LN seems to be the site in which
the primary response develops specifically on day 4 after regional
injection of the pulsed BMDC; both T cells and B cells take part in
the antigen-specific LN response, but T cells are not essential in
mice that lack T cells congenitally; resistance to otherwise lethal
bacterial challenge in the peritoneum involves antigen-specific
trapping of the bacteria, but allows them to proliferate in situ
before being killed; and some mice resist bacterial challenge
without producing IgG antibody detectable in the blood. This
comprehensive view of the development of antigen-specific




All animal experiments were conducted at the Weizmann
Institute of Science and approved by the Weizmann Institutional
Animal Care and Use Committee (IACUC) (Permit Number:
04630909-3) according to the Israel law and the National
Research Council guide (Guide for the Care and Use of
Laboratory Animals 2010).
Mice
Female C57BL/6 mice were purchased from Harlan Olac
(Bicester, UK). Female B6.129P2-Tcrb
tm1Mom/J, B6.129P2-
Tcrd
tm1Mom/J were purchased from the Jackson Laboratory (Bar
Harbor, ME). CCR7 deficient mice (C57BL/6 background) [31]
were kindly provided by Guy Shakhar (The Weizmann institute of
Science). CD80/86 [32], MHCII [33], CD40 [34] and beta2M
[35] deficient mice. All the mice were used at the age of 8–10 wk.
Reagents
Lyophilized pathogenic Pn type 3 and type 4 bacteria and PS4
and PS3 (,100 KD) were purchased from ATCC (Manassas, VA);
LPS Salmonella Minnesota was purchased from Sigma-Aldrich
(Rehovot, Israel); Alexa fluor 633, CFSE (Molecular probes,
Invitrogen; Carlsbad, CA) Glutaraldehide (GH), and Paraformal-
dehyde (PFA) were purchased from Merck (Darmstadt, Germany)
and Methyl-
3H-Thymidin from Amersham Biosciences (Piscat-
away, NJ).
Preparation of BMDC
BMDC were prepared as described earlier [12]. Briefly, mice
were sacrificed and BM was extracted from femura and tibiae by
flushing the shaft with PBS. Red blood cells were lysed using red
blood lysis buffer (Sigma-Aldrich), and the remaining cells were
seeded on non-tissue culture Petri plates at a density of 4610
6 cells
per plate in medium (RPMI-1640, 10% FCS, 5610
25 M2 -
mercapto ethanol, penicillin/streptomycin) containing mouse
recombinant GM-CSF 40 ng/ml (ProsPec; Rehovot, Israel). The
culture medium was replenished every 3 days and the loosely
adherent DC were collected after 8–10 days and used for further
studies. To induce DC maturation, day 8 cultures were treated
with LPS (1 mg/ml) for 24 hours.
Purification of naı ¨ve splenic B and T cells
Spleens from naı ¨ve mice were isolated and meshed. Spleen cell
suspensions were depleted of red blood cells by treatment with red
blood lysis buffer (Sigma-Aldrich). B cells were then purified by
negative selection with a B cell isolation kit containing biotin-
conjugated mAbs to CD43, CD4, and Ter-119 (Miltenyi Biotec;
Auburn, CA). T cells were purified by positive selection of CD3
+
cells using a T cell isolation kit (Miltenyi Biotec).
Cytokine determination in culture supernatants
The presence of cytokines in culture supernatants was de-
termined by ELISA for IFNc (Endogen Inc.; Boston, Mass) and
IL-17 (BD Pharmingen, San Diego, CA) following the manufac-
turer’s instructions using Maxisorp 96-well plates. Standard curves
were established using mouse recombinant cytokines.
PS4 labeling with Alexa fluor 633
The preparation of labeled PS4 was performed in collaboration
with Mati Fridkin (Weizmann Institute of Science): PS4 was
dissolved in DDW (10 mg/ml), and 15 mg (0.1 mmol) of 1,3-
diaminopropane di-hydrochloride dissolved in DDW was added.
N-ethyl-N9-(3-dimethylaminopropyl)-carbodiimide (EDC?HCL)
(19 mg; 0.1 mmol) (Sigma-Aldrich) was then added, and the
reaction mixture was kept for 4 hours at room temperature. Then
another portion of EDC?HCL (9.5 mg; 0.05 mmol) was added.
After 10 hours at room temperature, the clear homogenous
reaction mixture was extensively dialyzed against 0.1N acetic acid
at 4uC to remove low-molecular weight molecules. The pH was
adjusted to 7.5 with 0.1N KHCO3 solution followed by the
addition of Alexa fluor 633 (19 mg; ,0.05 mmol). After standing
overnight at room temperature, the product solution was dialyzed
extensively against DDW at 4uC and then against 0.05N acetic
acid. The solution was divided into aliquots and kept at 4uC with
0.01M sodium azid.
Flow cytometric analysis and immunocytochemistry
The presence of PS4 on the BMDC surface was observed using
flow cytometry. BMDC (1610
6 per tube) were pulsed with the
Alexafluor 633 labeled-PS4 at 4uCo r3 7 uC as indicated in the text.
The cells were washed with PBS/1% BSA and then incubated for
15 min with the anti-FccRIII/II 2.4G2 Ab (BD Pharmingen, San
Diego, CA) to block nonspecific binding. After washing, the cells
were stained with specific surface marker Abs: anti-mouse CD1d-
PE, I-AE-PE (eBioscience; San Diego, CA), CD11c-APC (Biole-
gends; San Diego, CA) or H-2K
b-FITC (CALTAG Laboratories)
for an additional 15 minutes on ice. The cells were then washed
and transferred to 10 mm glass cover-slips (Deckglaser, Germany)
in 24-well plates (2610
5/well) for 30 minutes at 37uC to allow
adherence. The cells then were fixed with 4% PFA for 15 minutes
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slides with elvanol. The cells were also analyzed by flow cytometry
analysis using the FACSort machine and the CellQuest software
(BD Biosciences).
Vaccination with PS-pulsed BMDC, with un-pulsed BMDC
or with soluble PS
BMDC were grown as described above. Part of the cells was
stimulated with LPS 1 mg/ml O/N to induce maturation. LPS-
stimulated and non-stimulated BMDC were collected into conical
tubes and incubated with PS 100 mg/ml (per 5610
6 cells) for
1 hour at 37uC. Then the cells were harvested and extensively
washed with ice–cold PBS to remove unbound PS and were
injected IP (200 mL per mouse) or IFP (25 mL per mouse). Control
LPS-stimulated unpulsed BMDC or soluble PS (100 mg/ml) and
LPS (1 mg/ml) were injected as well.
Pn bacteria
Lyophilized Pn type 3 or type 4 bacteria and PS antigen were
obtained from the ATCC. Pn bacteria were reconstituted and sub-
cultured on sheep’s blood agar (Hy Laboratories, Rehovot, Israel)
and the colonies were re-suspended in brain-heart infusion (BHI)
broth (Hy Laboratories). After 6 h of growth, the bacterial cultures
were aliquoted and stored at 280uC in medium with 25%
glycerol. For pneumococcal challenge, a frozen aliquot of Pn
bacteria was thawed in BHI broth and was grown for 6 h at 37uC,
and then transferred to ice until injection. Bacterial growth was
estimated by the level of turbidity using an OD reader at 545 nm.
The actual dose of viable bacteria injected in each challenge was
determined by plating dilutions of the bacteria on sheep’s blood
agar for 24 h at 37uC and counting the number of CFU; one CFU
was considered to represent one bacterium sown on the plate at
a limiting dilution. Pneumococcal virulence was maintained by
periodic passage in mice: mice were injected with 100 Pn CFU,
and 20 h later the spleens were harvested, passed through a wire
mesh, and seeded on sheep’s blood agar. The bacteria were then
prepared as indicated above. To determine the minimal lethal
dose, naive C57BL/6 mice (3 mice per group) were injected IP
with 200 ml of serially diluted bacteria, and survival was de-
termined daily for 2 wk. All naive mice challenged with two or
more CFU died within one day of challenge. The minimal lethal
dose that killed half of the challenged mice (LD50) was determined
to be one bacterium per mouse.
ELISA serology
Vaccinated mice were bled two days before bacterial challenge
and serum samples were tested in ELISA; 96-well maxisorp plates
(Nunc; Rochester, NY) were coated with the PS antigen (10 mg/
ml) O/N at 4uC. The plates were washed and blocked with
100 mL of BSA 1% for 1 hour R/T. Then, dilutions of the serum
samples in PBS/1% BSA (1:100) were added for 1.5 hours R/T,
then AP-conjugated anti-mouse IgG (Jackson Laboratories), IgM,
IgA or IgE (Southernbiotech Lab; Birmingham, Alabama) for
1 hour R/T and finally phosphate substrate. The yellowish color
was read at 405 nm.
Proliferation test of draining LN lymphocytes
Labeled-thymidin proliferation assay: Draining LN, non-drain-
ing LN and spleens were isolated and meshed. The cells were
incubated in quadruplicate in round-bottom 96-well plates (5610
5
cells per well) at 37uCi n5 %C O 2 in 200 ml of RPMI
supplemented with 1% syngeneic naı ¨ve mouse serum, 5610
25
M beta-ME, L-glutamate, sodium pyruvate, non-essential amino
acids, and penicillin/streptomycin. PS4 or PS3 were added
(50 mg/ml) to the culture. After 85 h, the cells were pulsed with
1 mCi of [
3H]thymidine for 12 h, and [
3H]thymidine incorpora-
tion was measured using a 96-well plate beta counter. The mean
cpm 6 SD were calculated for each quadruplicate.
CFSE-based proliferation assay: Draining LN, non-draining LN
and spleens were isolated and meshed. The cells were labeled with
CFSE (C-1157; Invitrogen) and cultured together with PS4 50 mg/
ml in medium supplemented with 1% syngeneic naı ¨ve mouse
serum in 96-well plates. After 96 hours, the cells were collected
and stained for anti- mouse CD3-biotin (eBioscience):cy5-SA
(Jackson Lab) or anti- mouse CD19-APC (eBioscience). The cells
were then washed and examined by flow cytometry.
Examination of peritoneal lavage and blood samples of
challenged mice by flow cytometry, and CFU counting
assay
Vaccinated mice were challenged with Pn4 bacteria. Before
challenge (time 0) and different time points after challenge, blood
samples of vaccinated mice were collected into heparin. Blood and
peritoneal lavage samples were tested for living bacteria by CFU
counting assay; the samples were diluted or were put as is on blood
agar plates. Twenty-four hours later, CFU were count, and the
total CFU number was calculated.
Statistics
The InStat 2.01 program (GraphPad) was used for statistical
analysis. Statistical analysis was performed using the two-sided
Welch T test, Wilcoxson non-parametric test or Fisher’s exact Chi
test. Differences were considered statistically significant at p,0.05.
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